The Lancet Gastroenterology & Hepatology in conversation with
Un podcast de The Lancet Group
88 Épisodes
-
Tim Vanuytsel on spore-forming probiotics in functional dyspepsia
Publié: 09/09/2021 -
Raymond Henderson on the economic burden of colorectal cancer
Publié: 12/08/2021 -
Sigurður Ólafsson on eliminating hepatitis C in Iceland
Publié: 22/06/2021 -
Caroline Ovadia on intrahepatic cholestasis of pregnancy
Publié: 03/06/2021 -
Matthew Akiyama on hepatitis C in prisons
Publié: 12/04/2021 -
Monika Sarkar on reproductive health in women with liver disease
Publié: 11/03/2021 -
Colorectal cancer risk in patients with Crohn’s disease
Publié: 12/03/2020 -
Liver damage in young adults
Publié: 17/01/2020 -
Treatments for IBS
Publié: 14/01/2020 -
Statins and decompensated cirrhosis
Publié: 27/11/2019 -
Global burden of pancreatic cancer and colorectal cancer
Publié: 04/11/2019 -
Paediatric inflammatory bowel disease
Publié: 12/09/2019 -
Transplanting hepatitis C-infected hearts
Publié: 28/08/2019 -
Primary anastomosis as a treatment for diverticulitis
Publié: 31/07/2019 -
Faecal microbiota transplantation in IBS
Publié: 30/07/2019 -
Treating faecal incontinence in women
Publié: 17/07/2019 -
Viral hepatitis in children & adolescents
Publié: 23/05/2019 -
Whole-body MRI: the STREAMLINE trials
Publié: 11/05/2019 -
A new drug for short bowel syndrome
Publié: 05/04/2019 -
Eosinophilic oesophagitis endotype classification
Publié: 09/03/2019
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
